tors influencing renal and extrarenal erythropoietin production and the effects of androgens on erythropoiesis reflect the recent resurgence of interest in this subject. There is now evidence that renal and serum factors react to form erythropoietin in a similar fashion to renin and angiotensinogen although the two systems are functionally distinct. In humans and other mammals androgens probably stimulate erythropoiesis both by enhancing the production of renal erythrogenin in response to normal stimuli and possibly by a direct effect of their ,B-hydroxy-steroid metabolites on the bone marrow. Also of topical interest are the renal prostaglandins whose nature and function are reviewed. They appear to be the mediators of the antihypertensive effect of extracts of renal tissue. In vivo they can be released by angiotensin II but this response is modified by the plasma level of renin or related factors.
Chapters on the place of beta-adrenergic blockade in the treatment of renal hypertension and on the effect of various drugs on renal volume are of interest to the clinician. The book can be recommended to all who are engaged in renal research not least because of its impressive collection of 682 references.
M. H. Winterborn
Atherosclerosis-Proceedings of the Second International Symposium. R. J. JONES (ed.), Springer-Verlag, New York, 1970. Pp. 706 . DM65.
The first international symposium on Atherosclerosis which was held in Athens, 1966 was a great success and the research interest in this field has undoubtedly increased so rapidly that it has again warranted an airing of some of the more recent findings. This second symposium held in Chicago, 1969 has presented us with an enormous amount of material valuable to research workers and to the physician.
The volume is divided systematically into sections which deal with pathogenesis and thrombosis, serum lipoproteins, metabolism of triglycerides and sterols, environmnetal factors in coronary disease. nutrition, the effect of drugs, control trials and trial planning. There are talks by invited experts on each of the above topics and also reports of selected papers. Most valuable is the discussion after each series of talks. The casual reader may be content with reading the general talks and the discussions, as much knowledge emerges from these. Pathogenesis Previous work was more related to the morphology and arterial wall chemical composition, whereas in the present volume more stress is placed on the energetics of the arterial wall and factors affecting repair mechanism. Reactions produced by lipoproteins or their components (cholesterol or ester cholesterol) in medial cells, alters cell metabolism resulting in severe cell proliferation which can narrow the artery's lumen.
Little further progress has been made on aortic synthesis of lipids and it has been reiterated here that lipid accumulation in the aorta of cholesterol fed animals (squirrel monkeys in this instant) is attributed to two mechanisms, aortic synthesis and lipid infiltration. Free cholesterol and sphingomyelin arise by deposition from plasma beta lipoproteins and other phospholipids accumulate through direct aortic synthesis whilst ester cholesterol probably arises by intracellular cholesterol esterification. The relative contribution of cholesterol synthesis by the arterial wall to cholesterol accumulation is an unsolved question although it has been experimentally established that sterol synthesis occurs in artery walls and is enhanced when atherosclerosis is present. The foam cells play an important part in the total biosynthetic mechanism.
The kinetic studies of lipid influx and accumulation do not support the hypothesis that the accumulation of lipid in the atheroma is a simple filtration and retention of lipoproteins. Cholesterol feeding causes a gradual increase in the permeability of the arterial wall which promotes the influx and retention of serum lipoprotein cholesterol.
It appears that a newer approach which may throw some light on the infiltration of plasma lipoproteins and accumulation of different types of lipid in the aorta comes from studies using immuno fluorescent microscopy and immunoelectrophoresis of lipoproteins extracted from the arterial wall. In human autopsy material from subjects with coronary heart disease when aortas with a minimum atherosclerosis were chosen they were found to have high levels of immuno-beta cholesterol. Although the significance of this finding is not clear a more complete explanation of these findings will undoubtedly be forthcoming.
Recent findings indicated that the smooth muscle cells and endothelial cells of arteries are not inactive cellular constituents. The older hypothesis suggests that primary arterial changes were associated with the degeneration and necrosis of these cells with or without visible lipid accumulation and that multiplication of cells with accompanying dedifferentiation is a secondary phenomena. It has now been suggested that the first cell reaction in artery walls in atherosclerosis is not necrosis but excessive proliferation of smooth muscle cells with or without dedifferentiation.
On the thrombotic side, platelet aggregation and the effect of platelet lysosomal enzymes have been shown to cause arterial cell damage and possibly increase the permeability of the endothelium to infiltration and deposition of plasma proteins in the vessel wall. Lipoproteins In this region research is still in the early stages although significant advances are reported on the study of the structure of apoproteins of the serum lipoproteins. The accent has shifted from the biosynthesis of lipids to the biosynthesis of lipoproteins and especially to the low density (L.D.L.) and very low density (V.L.D.L.) lipoproteins. Although considerable progress has been reported, the site and sequence of assembly of the complete V.L.D.L. particle and the mechanism of release from the cell into the circulation are important aspects which require to be investigated. In biliary obstruction a new lipoprotein fraction has been demonstrated immuno-chemically, the LP-X fraction. This fraction contains 6 % protein, 65 % phospholipid, 25%cholesterol and 3 %triglyceride.
A recent concept of autoimmune hyperlipidaemia (A.I.H.) has been reviewed. This atherogenic metabolic disease is of immune origin in which soluble complexes of antibodies with lipoproteins, found to accumulate in the circulating blood, are reported to be highly atherogenic.
The important question of the relation of hypertriglyceridaemia and hyperinsulinemia has been discussed and the present conclusions indicate that hyperglyceridemia is often but not always associated with hyperinsulinemia. In individual cases it is difficult to establish whether they are casually related or only coexistent disorders induced by a common indulging factor such as obesity or glucose intolerance.
A study of sterol balance is of particular importance in atherosclerosis and methods of assessing the turnover of cholesterol have been discussed in some detail. The reliability of measuring cholesterol excretion and synthesis are well debated. Specific data related to cholestryl esters (C.E.) show that C.E. are separated into three pools corresponding to the three classes of lipoproteins. The H.D.L.-C.E. shows the greatest and L.D.L.-C.E. the smallest fractional turnover rate and these rates are not altered by therapy with cholestyramine or clofibrate.
A study on the effect of diet on hyperlipoproteinaemia indicated that polyunsaturated fat in the diet did not cause enhanced faecal bile acid excretion in Type II patients. This divergence between the normal subject and the Type II patient may indicate one facet of the metabolic abnormality in Type II patients.
Current epidemiological studies on atherosclerosis have been reported from Europe, Africa, Israel, India, the Pacific, Central America, the Caribbean and North America. It is impossible to attempt a summary of these studies which are reviewed in considerable detail. The association of risk factors for coronary heart disease (C.H.D.) and atherosclerotic lesions, derived from data from the International Atherosclerosis Project, indicate that the lesions are shown to be related to serum cholesterol and dietary fat when comparing populations. However, insufficient data are available to confirm such association on an individual basis within a population. Lesions were greater in hypertensive and diabetic individuals and in heavy cigarette smokers. No consistent association of atherosclerotic lesions were observed with physical activity or obesity.
In another study a faster resting heart rate was reported to be an independent coronary risk factor. Nutrition Toxic factors in nutrients such as peanut and coconut oil have been indicated and the increased incidence of cardiovascular disease in areas with soft water suggests a possible protective role of the minerals present in hard water supplies. Another study suggests a composition of diets for reducing blood cholesterol and maintaining its low level. This diet must be low in myristic and palmitic acids, it should contain less than 350 mg cholesterol and be relatively rich in polyunsaturated fatty acids.
A statistical link between raised blood sugar levels and incidence of atherosclerotic arterial disease has been indicated. The nature of the association is less clear. A direct effect of raised blood sugar may involve localised osmotic damage to the arterial intima due to accumulation of non-diffusible sorbitol. Drugs The effects of clofibrate and the possible mechanisms of its action are reviewed. The effects show a decrease in plasma lipoprotein levels, fibrinogen levels and platelet adhesiveness and an increase in platelet survival, body weight and liver weight. Numerous mechanisms of drug action have been suggested but the mechanism is still not completely understood. The effect of non absorbant hypolipidaemic agents such as cholystyramine, neomycin or DEAE Sephadex on cholesterol metabolism in man are also reviewed.
Increased levels of free fatty acids and triglycerides are implicated in the pathogenesis of atherosclerosis and effective chemotherapy against these high levels appears to be promising.
A review of drugs affecting platelet function is presented and aspirin has been cited as a potential agent in preventing the formation of platelet thrombi. Various chemically useful drugs and their modes of interaction with norepinepherine storage mechanisms are also reviewed.
The design of primary and secondary preventive trials have been reviewed in some detail and it has been stressed that the highest exercise of scientific 63 judgment is called for in such trials since the possibilities of independent repetition are severely limited by costs and the time involved. An account is given of progress of a preliminary preventive trial using clofibrate to observe its effect on the incidence of heart disease by reducing elevated serum lipids in healthy men. Ten thousand men aged 30-59 have been admitted to the study which is based in Edinburgh, Prague and Budapest. The degree of reduction of elevated serum lipids is regarded as satisfactory and no side effects of consequence have occurred.
Some aspects of the progress in drug trials of secondary prevention with particular reference to the coronary drug project has been revealed by a very large panel of experts under the authorship of 'the Coronary Drug Project Research Group'.
Program planning for control of atherosclerosis has also been aired and the view expressed that a definitive preventive trial sponsored by the American Government appears to be absolutely essential.
J. D. Billimoria
Control of Human Fertility. E. DICZFALUSY and U. BoRELL (eds.), Wiley Interscience Division, London, 1971. Pp. 352. £9·25. This book contains 18 papers presented at the 15th Nobel Symposium in Sweden in May, 1970. Various experimental approaches to fertility control were discussed as well as recent advances in methods of stimulating ovarian function. The early chapters describe the oral contraceptives based on oestrogens and progesterone and they are followed by contributions on non-steroidal contraceptives, intrauterine devices and by reviews on the factors influencing fertilisation and implantation and on immunological aspects of reproduction. Representatives of W.H.O. discussed problems related to induced abortions and the various health aspects of the use of fertility controlling agents. Each contribution is followed by a discussion which often adds to the interest of the chapter.
The first paper by Egon Diczfalusy sets a predictably high standard which is generally maintained throughout the book. With his usual clarity and awareness of existing problems Professor Diczfalusy reviews the chemistry of the steroids used as oral contraceptives and discusses their metabolism and mode of action. In developing new contraceptives it is hazardous to extrapolate to the human observations made on other species but this has to be done. There is great public interest in any new product and it is widely expected that the drug will exhibit its desired effect over long periods with never any side effect. Then when products are
